Initial Clinical Experience with Dideoxynucleosides as Single Agents and in Combination Therapy
- 17 December 1990
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 616 (1) , 328-343
- https://doi.org/10.1111/j.1749-6632.1990.tb17853.x
Abstract
Click on the article title to read more.Keywords
This publication has 43 references indexed in Scilit:
- Bone Marrow Toxicity of DideoxyinosineNew England Journal of Medicine, 1989
- Clinical Pharmacology of 3'-Azido-2',3'-Dideoxythymidine (Zidovudine) and Related DideoxynucleosidesNew England Journal of Medicine, 1989
- Neuropsychological Outcome of Zidovudine (AZT) Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1988
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- Severe Polymyositis-like Syndrome Associated with Zidovudine Therapy of AIDS and ARCNew England Journal of Medicine, 1988
- Azidothymidine in the Treatment of AIDSNew England Journal of Medicine, 1988
- Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1987
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Development of Antiretroviral Therapy for the Acquired Immunodeficiency Syndrome and Related DisordersNew England Journal of Medicine, 1987